Streetbeat News

SNDL

SNDL Inc.

https://www.sndlgroup.com

Industry

Drug Manufacturers - Specialty & Generic

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

Open

2.04

Mkt cap

525M

Volume

3.2M

High

2.05

P/E Ratio

-6.39

52-wk high

2.93

Low

1.96

Div yield

N/A

52-wk low

1.30

The article lists the marijuana stocks that gained and lost on November 2, 2023. The biggest gainers were Rocky Mountain High (OTC:RMHB), Global Compliance (OTC:FUAPF), and Psychemedics (NASDAQ:PMD), while the biggest losers were EVIO (OTC:EVIO), Nextleaf Solutions (OTC:OILFF), and RIV Capital (OTC:CNPOF).

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 9:30 pm

The Drug Enforcement Administration (DEA) plans to significantly increase domestic production of delta-9 THC and other cannabinoids for research purposes in 2024. The agency also plans to maintain high levels of psychedelics production. The DEA has proposed nearly doubling the amount of psilocybin, psilocyn, and delta-9 THC manufactured compared to initial levels set for this year, while quintupling the production of ibogaine. The DEA's move comes amid a transition away from cannabinoid imports to domestic manufacturing.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 6:45 pm

Senate Majority Leader Chuck Schumer plans to amend the Secure and Fair Enforcement Regulation (SAFER) Banking Act to include criminal justice provisions. The amendments will be borrowed from a separate federal legalization bill, the Cannabis Administration and Opportunity Act (CAOA), and will include measures such as resentencing for current federal cannabis prisoners. Despite uncertainties around the new GOP House speaker's stance on cannabis, key Senate Republicans are prepared to move forward with the legislation.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 3:16 pm

The cannabis sector experienced significant movement on October 31, 2023. Notable gainers included Choom Holdings, MPX International, and Rocky Mountain High, with shares closing up 9900.00%, 1100.00%, and 100.00% respectively. On the other hand, Global Hemp Group, EVIO, and Target Group were among the biggest losers, with shares closing down 55.11%, 50.00%, and 28.36% respectively.

Portfolio Pulse from Benzinga Insights

October 31, 2023 | 9:30 pm

A key House committee will consider amendments to a large-scale spending bill that would prevent drug testing of certain federal job applicants for marijuana and end the blockade that has kept Washington, D.C. from legalizing cannabis sales. The amendments were filed to Fiscal Year 2024 appropriations legislation covering Financial Services and General Government (FSGG). The GOP-controlled House Rules Committee, which has rejected numerous drug policy reform measures in recent months, will take up the amendments.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 3:00 pm

SNDL Inc. and Nova Cannabis Inc. have announced an extension of the closing date for their strategic partnership to November 30, 2023, due to a continued review by a provincial regulator. The maturity date of Nova's revolving credit facility with SNDL has also been extended to the same date.

Portfolio Pulse from Charles Gross

October 30, 2023 | 11:28 am

Massachusetts cannabis businesses are challenging the constitutionality of federal drug laws, according to a Politico report. This could potentially impact the legal landscape for cannabis businesses across the US.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:30 pm

The marijuana stock market experienced a bearish Wednesday with several stocks seeing significant changes. MGC Pharmaceuticals, Psychemedics, Body and Mind, iAnthus Capital Holdings, Nextleaf Solutions, Indiva, Leafbuyer Techs, GreenGro Technologies, CV Sciences, Kaya Holdings, 22nd Century Group, CLS Holdings USA, EnWave, and Cansortium saw gains. However, EVIO, AusCann Group Holdings, Item 9 Labs, 1933 Industries, MJ Holdings, Canopy Growth, Rocky Mountain High, C21 Investments, Cresco Labs, Curaleaf Holdings, Global Compliance, Aurora Cannabis, SOL Global Investments, Tilray Brands, Trulieve Cannabis, Zoned Properties, Cara Therapeutics, OrganiGram Holdings, Village Farms International, Cronos Group, SNDL, GrowGeneration, Green Thumb Industries, Neptune Wellness Solutions, 4Front Ventures, and Charlottes Web Holdings saw losses.

Portfolio Pulse from Benzinga Insights

October 25, 2023 | 9:30 pm

The newly elected U.S. House Speaker, Rep. Mike Johnson, has a history of voting against marijuana-related measures, including banking, research, and legalization. This could potentially impact the advancement of the Secure and Fair Enforcement Regulation (SAFER) Banking Act, which is currently being worked on by Senate leadership. Johnson's stance on marijuana could also affect the future of cannabis research and legalization efforts.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 7:37 pm

Bipartisan House lawmakers have refiled a bill to federally legalize marijuana, the States Reform Act, which was first introduced in 2021. The bill aims to end federal cannabis prohibition and treat marijuana similarly to alcohol. It includes provisions for expungements for non-violent cannabis convictions and imposes an excise tax, the revenue from which would support community reinvestment, law enforcement, and Small Business Administration activities. The bill's prospects of advancing under the GOP-controlled House are uncertain.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 3:26 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.